Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.85USD
17 May 2019
Change (% chg)

-- (--)
Prev Close
$4.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,332
52-wk High
$6.77
52-wk Low
$2.10

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)

Overall

Beta: --
Market Cap(Mil.): $56.33
Shares Outstanding(Mil.): 10.04
Dividend: --
Yield (%): --

Financials

  ATXI.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -0.53 -- --
ROI: -- 14.23 13.82
ROE: -- 15.46 15.24

Earnings vs. Estimates